These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25 related articles for article (PubMed ID: 18295394)
1. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer. Zelefsky MJ; Yamada Y; Kollmeier MA; Shippy AM; Nedelka MA Eur Urol; 2008 Jun; 53(6):1172-9. PubMed ID: 18222596 [TBL] [Abstract][Full Text] [Related]
2. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer. Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427 [TBL] [Abstract][Full Text] [Related]
3. Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality. Zelefsky MJ; Shi W; Yamada Y; Kollmeier MA; Cox B; Park J; Seshan VE Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1350-6. PubMed ID: 19515504 [TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
5. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526 [TBL] [Abstract][Full Text] [Related]
6. Clinical stage T3 prostate cancer: the added value of three-dimensional conformal/intensity-modulated external-beam radiotherapy. Bolla M Eur Urol; 2008 Jun; 53(6):1104-6; discussion 1106-8. PubMed ID: 18295394 [No Abstract] [Full Text] [Related]
7. How quality influences the clinical outcome of external beam radiotherapy for localized prostate cancer. van Vulpen M; van der Heide UA; van Moorselaar JR BJU Int; 2008 Apr; 101(8):944-7. PubMed ID: 18070170 [TBL] [Abstract][Full Text] [Related]
8. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer. D'Ambrosio DJ; Pollack A; Harris EE; Price RA; Verhey LJ; Roach M; Demanes DJ; Steinberg ML; Potters L; Wallner PE; Konski A Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):671-7. PubMed ID: 18262085 [No Abstract] [Full Text] [Related]
9. Intensity modulated radiation therapy. Maddock PG Med Health R I; 2006 Feb; 89(2):76-8. PubMed ID: 16583667 [No Abstract] [Full Text] [Related]
10. Radiation management of prostate cancer. Glicksman AS Med Health R I; 2006 Feb; 89(2):74-5. PubMed ID: 16583666 [No Abstract] [Full Text] [Related]
11. [Problems of radiotherapy for locally advanced prostate neoplasms]. Goldobenko GV; Kanaev SV; Tkachev SI; Ivanov VM Vopr Onkol; 1999; 45(6):696-701. PubMed ID: 10703527 [No Abstract] [Full Text] [Related]